Introduction: Migraine headaches are the 7th leading cause of disability globally, according to the world health organization. Hormonal factors may impact it, and it is ranked as the eleventh most common health problem among women throughout peri- and postmenopausal periods Purpose: This study was done to examine the impact of TENS on migraine in postmenopausal women. Subjects: fifty-two postmenopausal women with migraine. They will be selected from the outpatient clinic of El-Hussein University Hospital. The participants will be randomized into two equivalent groups: Group A (study group): It involved 26 women who will receive TENS for 20 minutes, 3 sessions per week for twelve weeks. Group B (control group): It involved 26 women who will receive advices only. Methods: Assessments were conducted using the Visual Analogue Scale (VAS) and the Migraine Disability Assessment Schedule (MIDAS) both at baseline and following 4 weeks. Results: After treatment, there was a mean difference of -2.92 in VAS scores across the groups. After treatment, the VAS of the study group was significantly lower than the control group. After treatment, there was a mean difference of 6.89 MIDAS scores across the groups. After treatment, MIDAS decreased significantly in the study group compared to the control group.

Conclusion: Transcutaneous electrical nerve stimulation can be utilized on treatment of migraine in postmenopausal women. It has significant impact on VAS and MIDAS rather than advices only.